Search
Patexia Research
Case number 2016-1652

Cubist Pharmaceuticals LLC v. Mylan Laboratories Limited > Documents

Date Field Doc. No.Description (Pages)
Jul 15, 2016 51 Mandate issued to the United States District Court for the District of Delaware. Service as of this date by Clerk of Court. [351134] [16-1652, 16-1653, 16-1796, 16-1853, 16-2057] [SJ] [Entered: 07/15/2016 11:56 AM] (2)
May 24, 2016 50 ORDER filed. The judgments in the above-captioned appeals are summarily affirmed. All other pending motions [26] [325493-2] are denied as moot. Each side shall bear its own costs. Service: 05/24/2016 by clerk. [337846] [16-1652, 16-1653, 16-1796, 16-1853, 16-2057] [LMS] [Entered: 05/24/2016 10:28 AM] (4)
May 23, 2016 49 Docketing Statement for the Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 05/23/2016 by email. [337496] [Stuart Sender] [Entered: 05/23/2016 11:37 AM] (4)
May 23, 2016 48 Certificate of Interest for the Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 05/23/2016 by email. [337491] [Stuart Sender] [Entered: 05/23/2016 11:35 AM] (2)
May 20, 2016 47 Entry of appearance for Ellen T. Lowenthal as of counsel for Dr. Reddy's Laboratories, Ltd. Dr. Reddy's Laboratories, Inc.. Service: 05/20/2016 by email. [337183] [Ellen Lowenthal] [Entered: 05/20/2016 01:56 PM] (2)
May 20, 2016 46 Entry of appearance for Stuart D. Sender as principal counsel for Dr. Reddy's Laboratories, Inc., and Dr. Reddy's Laboratories, Ltd.. Service: 05/20/2016 by email. [337096] [Stuart Sender] [Entered: 05/20/2016 11:45 AM] (2)
May 18, 2016 45 Note to file: The following cases are associated:16-1652 Lead with 16-1653, 16-1796, 16-1853, 16-2057 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [336412] [16-1652, 16-1653, 16-1796, 16-1853, 16-2057] [JCA] [Entered: 05/18/2016 12:46 PM] (0)
May 18, 2016 44 ORDER consolidating appeals (16-1652, 16-1653, 16-1796, 16-1853, 16-2057). These appeals appear to be related. We consolidate the cases and thus one set of briefs should be filed for the four appeals. The revised official caption is reflected on the order. The briefing schedule is stayed.Service as of this date by Clerk of Court. [336406] [16-2057, 16-1652, 16-1653, 16-1796, 16-1853] [JCA] [Entered: 05/18/2016 12:40 PM] (2)
May 12, 2016 43 REPLY of Appellees Agila Specialties Inc. and Mylan Laboratories Limited to response filed by Appellant in 16-1652 , Doc. No [39]. Service: 05/12/2016 by email. [334628] [Nicole Stafford] [Entered: 05/12/2016 02:41 PM] (12)
May 5, 2016 42 REPLY of Appellee Fresenius Kabi USA, LLC to response filed by Appellant in 16-1652 , Doc. No [37]. Service: 05/05/2016 by email. [332649] [William Jay] [Entered: 05/05/2016 06:17 PM] (16)
May 3, 2016 41 Note to file: The following cases are associated:16-1652 Lead with 16-1853 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [331768] [LN] [Entered: 05/03/2016 02:56 PM] (0)
May 3, 2016 40 ORDER consolidating appeals (16-1652, 16-1653, 16-1796, 16-1853). These appeals appear to be related. We consolidate the cases and thus one set of briefs should be filed for the four appeals. The revised official caption is reflected on the order. The briefing schedule is stayed pending the court's resolution of the motions in 16-1652, -1653, -1796. Service as of this date by Clerk of Court. [331763] [LN] [Entered: 05/03/2016 02:53 PM] (2)
May 2, 2016 39 RESPONSE of Appellant Cubist Pharmaceuticals LLC to the motion to terminate appeal [33] filed by Appellees Mylan Laboratories Limited and Agila Specialties Inc. in 16-1652. Service: 05/02/2016 by email. [331401] [William Lee] [Entered: 05/02/2016 06:36 PM] (19)
Apr 28, 2016 38 Sealed or confidential document received [Exhibit 1 to Appellant Cubist Pharmaceutical LLC's Opposition to Appellee Fresenius Kabi USA, LLCs Motion for Summary Affirmance] (corresponding to Doc No. [37]) for Appellant Cubist Pharmaceuticals LLC. Service: 04/28/2016 by email. [330562] [William Lee] [Entered: 04/28/2016 06:32 PM] (0)
Apr 28, 2016 37 RESPONSE of Appellant Cubist Pharmaceuticals LLC to the motion for other relief [27] filed by Appellee Fresenius Kabi USA, LLC in 16-1652. Service: 04/28/2016 by email. [330561] [William Lee] [Entered: 04/28/2016 06:30 PM] (40)
Apr 25, 2016 36 REPLY of Appellant Cubist Pharmaceuticals LLC to response filed by Appellee in 16-1652 , Doc. No [35], response filed by Appellees in 16-1652 , Doc. No [32]. Service: 04/25/2016 by email. [329359] [William Lee] [Entered: 04/25/2016 03:12 PM] (5)
Apr 19, 2016 35 RESPONSE of Appellee Fresenius Kabi USA, LLC to the motion to stay appeal [26] filed by Appellant Cubist Pharmaceuticals LLC in 16-1652. Service: 04/19/2016 by email. [327554] [William Jay] [Entered: 04/19/2016 12:11 PM] (8)
Apr 18, 2016 34 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Agila Specialties Inc. and Mylan Laboratories Limited. Service: 04/18/2016 by email. [327344] [Nicole Stafford] [Entered: 04/18/2016 09:00 PM] (3)
Apr 18, 2016 33 MOTION of Appellees Agila Specialties Inc. and Mylan Laboratories Limited to terminate appeal through Dismissal or Summary Affirmance. [Consent: opposed]. Service: 04/18/2016 by email. [327338] [Nicole Stafford] [Entered: 04/18/2016 08:32 PM] (107)
Apr 18, 2016 32 RESPONSE of Appellees Agila Specialties Inc. and Mylan Laboratories Limited to the motion to stay appeal [26] filed by Appellant Cubist Pharmaceuticals LLC in 16-1652. Service: 04/18/2016 by email. [327334] [Nicole Stafford] [Entered: 04/18/2016 08:07 PM] (6)
Apr 18, 2016 31 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Sagent Pharmaceuticals, Inc.. Service: 04/18/2016 by email. [327323] [Stephen Auten] [Entered: 04/18/2016 06:17 PM] (4)
Apr 18, 2016 30 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Cubist Pharmaceuticals LLC. Service: 04/18/2016 by email. [327292] [William Lee] [Entered: 04/18/2016 04:45 PM] (4)
Apr 18, 2016 29 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Fresenius Kabi USA, LLC. Service: 04/18/2016 by email. [327250] [William Jay] [Entered: 04/18/2016 04:06 PM] (4)
Apr 14, 2016 26 MOTION of Appellant Cubist Pharmaceuticals LLC to stay appeal. Response/Opposition is due 04/28/2016 [Consent: partial consent]. Service: 04/14/2016 by email. [326603] [William Lee] [Entered: 04/14/2016 09:14 PM] (6)
Apr 14, 2016 27 MOTION of Appellee Fresenius Kabi USA, LLC for Summary Affirmance. Response/Opposition is due 04/28/2016 [Consent: opposed]. Service: 04/14/2016 by email. [326604] [William Jay] [Entered: 04/14/2016 10:04 PM] (38)
Apr 14, 2016 28 Sealed or confidential document received [Under Seal Motion by Defendant-Appellee Fresenius Kabi USA, LLC for Summary Affirmance] (corresponding to Doc No. [27]) for Appellee Fresenius Kabi USA, LLC. Service: 04/14/2016 by email. [326605] [William Jay] [Entered: 04/14/2016 10:09 PM] (0)
Apr 13, 2016 25 REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a), Fed. Cir. R. 47.3 and ECF-2(E) to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [326007] [LN] [Entered: 04/13/2016 11:13 AM] (0)
Apr 13, 2016 24 Note to file: The following cases are associated:16-1652 Lead with 16-1653 Consolidated and 16-1796 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [326002] [LN] [Entered: 04/13/2016 11:06 AM] (0)
Apr 13, 2016 23 ORDER consolidating appeals (16-1652 (Lead) with 16-1653 (Consolidated) and 16-1796 (Consolidated)). These appeals appear to be related. We consolidate the cases and thus one set of briefs should be filed for the three appeals. The revised official caption is reflected on the order. Appellant's brief is due no later than June 6, 2016. Service as of this date by Clerk of Court. [325999] [LN] [Entered: 04/13/2016 11:03 AM] (2)
Apr 7, 2016 22 Entry of appearance for Aden M. Allen as of counsel for Appellees Agila Specialties Inc. and Mylan Laboratories Limited. Service: 04/07/2016 by email. [324935] [Aden Allen] [Entered: 04/07/2016 07:09 PM] (2)
Mar 30, 2016 21 Entry of appearance for Eric C Arnell as of counsel for Appellee Mylan Laboratories Limited. Service: 03/30/2016 by email. [322988] [Eric Arnell] [Entered: 03/30/2016 05:48 PM] (1)
Mar 23, 2016 20 Entry of appearance for Yongdan Li as of counsel for Appellees Agila Specialties Inc. and Mylan Laboratories Limited. Service: 03/23/2016 by email. [321202] [Yongdan Li] [Entered: 03/23/2016 03:24 PM] (2)
Mar 18, 2016 19 Docketing Statement for the Appellees Agila Specialties Inc. and Mylan Laboratories Limited. Service: 03/18/2016 by email. [320158] [Nicole Stafford] [Entered: 03/18/2016 06:36 PM] (3)
Mar 18, 2016 18 Certificate of Interest for the Appellees Mylan Laboratories Limited Agila Specialties Inc. Service: 03/18/2016 by email. [320157]--[Edited 03/22/2016 by clerk to correct docket text to reflect the correct parties] [Nicole Stafford] [Entered: 03/18/2016 06:34 PM] (3)
Mar 18, 2016 17 Docketing Statement for the Appellant Cubist Pharmaceuticals LLC. Service: 03/18/2016 by email. [320148] [William Lee] [Entered: 03/18/2016 05:20 PM] (4)
Mar 18, 2016 16 Certificate of Interest for the Appellant Cubist Pharmaceuticals LLC. Service: 03/18/2016 by email. [320146] [William Lee] [Entered: 03/18/2016 05:19 PM] (2)
Mar 18, 2016 15 Entry of appearance for Mark C. Fleming as of counsel for Appellant Cubist Pharmaceuticals LLC. Service: 03/18/2016 by email. [320144] [Mark Fleming] [Entered: 03/18/2016 05:17 PM] (2)
Mar 18, 2016 14 Entry of appearance for William G. McElwain as of counsel for Appellant Cubist Pharmaceuticals LLC. Service: 03/18/2016 by email. [320142] [William McElwain] [Entered: 03/18/2016 05:15 PM] (2)
Mar 18, 2016 13 Entry of appearance for Lisa J. Pirozzolo as of counsel for Appellant Cubist Pharmaceuticals LLC. Service: 03/18/2016 by email. [320140] [Lisa Pirozzolo] [Entered: 03/18/2016 05:13 PM] (2)
Mar 18, 2016 12 Entry of appearance for William F. Lee as principal counsel for Appellant Cubist Pharmaceuticals LLC. Service: 03/18/2016 by email. [320139] [William Lee] [Entered: 03/18/2016 05:11 PM] (2)
Mar 18, 2016 11 Entry of appearance for Linnea P. Cipriano as of counsel for Appellee Fresenius Kabi USA, LLC. Service: 03/18/2016 by email. [320083] [Linnea Cipriano] [Entered: 03/18/2016 03:34 PM] (2)
Mar 18, 2016 10 Entry of appearance for Brian T. Burgess as of counsel for Appellee Fresenius Kabi USA, LLC. Service: 03/18/2016 by email. [320081] [Brian Burgess] [Entered: 03/18/2016 03:32 PM] (2)
Mar 18, 2016 9 Entry of appearance for Elizabeth J. Holland as of counsel for Appellee Fresenius Kabi USA, LLC. Service: 03/18/2016 by email. [320079] [Elizabeth Holland] [Entered: 03/18/2016 03:30 PM] (2)
Mar 18, 2016 8 Docketing Statement for the Appellee Fresenius Kabi USA, LLC. Service: 03/18/2016 by email. [320077] [Robert Cerwinski] [Entered: 03/18/2016 03:27 PM] (3)
Mar 18, 2016 7 Certificate of Interest for the Appellee Fresenius Kabi USA, LLC. Service: 03/18/2016 by email. [320076] [Robert Cerwinski] [Entered: 03/18/2016 03:27 PM] (2)
Mar 18, 2016 6 Entry of appearance for Robert V. Cerwinski as of counsel for Appellee Fresenius Kabi USA, LLC. Service: 03/18/2016 by email. [320075] [Robert Cerwinski] [Entered: 03/18/2016 03:25 PM] (2)
Mar 18, 2016 5 Entry of appearance for William M. Jay as principal counsel for Appellee Fresenius Kabi USA, LLC. Service: 03/18/2016 by email. [320072] [William Jay] [Entered: 03/18/2016 03:23 PM] (2)
Mar 8, 2016 4 Entry of appearance for Nicole W. Stafford as principal counsel for Appellees Agila Specialties Inc. and Mylan Laboratories Limited. Service: 03/08/2016 by email. [316727] [Nicole Stafford] [Entered: 03/08/2016 01:31 PM] (2)
Mar 8, 2016 3 Note to file: The following cases are associated:16-1652 Lead with 16-1653 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [316664] [LN] [Entered: 03/08/2016 11:51 AM] (0)
Mar 8, 2016 2 ORDER consolidating appeals (16-1652 (Lead) with 16- 1653 (Consolidated)). These appeals appear to be related. We consolidate the cases and thus one set of briefs should be filed for the two appeals. The revised official caption is reflected on the order. Appellant's opening brief is due no later than May 3, 2016. Service as of this date by Clerk of Court. [316660] [LN] [Entered: 03/08/2016 11:48 AM] (2)
Mar 4, 2016 1 Appeal docketed. Received: 03/03/2016. [316040]Entry of Appearance due 03/18/2016. Certificate of Interest is due on 03/18/2016. Docketing Statement due 03/18/2016. Appellant/Petitioner's brief is due 05/03/2016. [LN] [Entered: 03/04/2016 03:26 PM] (21)
Menu